Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at StockNews.com
StockNews.com upgraded shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning. A number of other equities research analysts have also weighed in on the company. Robert W. Baird lowered their price objective on Enanta Pharmaceuticals from $26.00 to […]
StockNews.com upgraded shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning. A number of other equities research analysts have also weighed in on the company. Robert W. Baird lowered their price objective on Enanta Pharmaceuticals from $26.00 to […]
